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The functional T cell repertoire is shaped in the 
thymus by positive and negative selection through 
interactions with MHC–peptide complexes ex-
pressed by thymic epithelial cells (TECs) and 
BM-derived APCs. Consequently, the size of the 
CD4 T  cell  compartment  and  its  diversity   
are determined by the complexity of the self- 
peptide repertoire presented by MHC class II 
molecules in the thymus (Marrack and Kappler, 
1997; Ebert et al., 2009; Lo et al., 2009).
The peptides for loading on MHC class II 
molecules are generated by sequential proteol-
ysis of endosomal proteins. At present, only cys-
teine proteases, including cathepsin (Cat)-S,   
-L, -F, and -H and asparaginyl endopeptidase 
(AEP), and the aspartyl proteases Cat-D and -E 
have  been  linked  to  antigen  (Ag)  processing 
(Hsing and Rudensky, 2005). However, some 
indirect evidence suggests that serine proteases 
and metalloproteases may also contribute to this 
latter process (Musson et al., 2003, 2006).
Although the different Ag-processing en-
zymes present broad specificities, the genera-
tion of some peptides may be strictly dependent 
on a given protease. Thus, Cat-S appeared nec-
essary for the generation of some class II epi-
topes of myoglobin (Myo), hen egg lysozyme 
(HEL), OVA, and KLH (Nakagawa et al., 1999; 
Shi et al., 1999; Plüger et al., 2002). Large-scale 
analysis of the I-Ab–bound peptides in embry-
onic fibroblast lines expressing either Cat-S or 
Cat-L also suggested that these two enzymes 
have some substrate specificities (Hsieh et al., 
2002).  Similarly, AEP  enhances  processing  of 
tetanus toxin for presentation by human EBV-B 
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Thymus-specific serine protease (TSSP) is a novel protease that may contribute to the 
generation of the peptide repertoire presented by MHC class II molecules in the thymus. 
Although TSSP deficiency has no quantitative impact on the development of CD4 T cells 
expressing a polyclonal T cell receptor (TCR) repertoire, the development of CD4 T cells 
expressing the OTII and Marilyn transgenic TCRs is impaired in TSSP-deficient mice. In this 
study, we assess the role of TSSP in shaping the functional endogenous polyclonal CD4  
T cell repertoire by analyzing the response of TSSP-deficient mice to several protein anti-
gens (Ags). Although TSSP-deficient mice responded normally to most of the Ags tested, 
they responded poorly to hen egg lysozyme (HEL). The impaired CD4 T cell response of 
TSSP-deficient mice to HEL correlated with significant alteration of the dominant TCR- 
chain repertoire expressed by HEL-specific CD4 T cells, suggesting that TSSP is necessary 
for the intrathymic development of cells expressing these TCRs. Thus, TSSP contributes to 
the diversification of the functional endogenous CD4 T cell TCR repertoire in the thymus.
© 2010 Viret et al.  This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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HEL12–27 peptide, by WT and Tssp/ spleen APCs using the 
BW-HEL clone that expresses mouse CD4 and an IAg7- 
restricted TCR specific for the NOD immunodominant epi-
tope HEL12–27. Both types of APCs presented equally well the 
HEL protein and HEL12–27 peptide to the BW-HEL clone, 
indicating that expression of TSSP by spleen APCs is not re-
quired for generation of the HEL immunodominant epitope 
in vitro (Fig. 2 A). To further determine whether TSSP was 
not  required  for  HEL  processing  in  vivo,  we  immunized 
Tssp/ and WT control mice with either the HEL protein or 
the HEL12–27 peptide and restimulated in vitro the primed 
CD4 T cells with the HEL12–27 peptide. We found that regard-
less of the nature of Ag used for the in vivo priming, the pro-
liferative response of CD4 T cells from Tssp/ mice was 
reduced as compared with that of WT CD4 T cells (Fig. 2,   
B and C). Finally, we compared the in vivo priming efficacy 
of peptide-loaded BM-derived WT and Tssp/ DCs and 
found that the two DC populations were equivalent at induc-
ing high response in WT control and low response in Tssp/ 
mice (Fig. 2 D).
To gain more insight into the reduced response of Tssp/ 
mice, we examined the proliferative profile of CFSE-labeled 
HEL-primed CD4 T cells upon in vitro restimulation. We 
found that at both day 3 and 6 after in vitro restimulation, 
CD4 T cells from Tssp/ deficient mice accomplished fewer 
divisions than those from WT mice (Fig. 2 E). No such differ-
ence was observed in response to OVA or anti-CD3 stimula-
tion (Fig. 2 E). These results strongly suggest that in mice 
lacking TSSP, the HEL-specific CD4 T cells might display a 
lower affinity than their WT counterparts.
cell lines but destroys a dominant epitope of myelin basic pro-
tein (Manoury et al., 1998, 2002). Whether and how these 
substrate specificities impact on the selection of the CD4   
T cell repertoire in the thymus remain unknown.
Thymus-specific serine protease (TSSP) is a putative ser-
ine protease that was initially described as a gene linked to a 
diabetes susceptibility locus in humans (Lie et al., 1999). Sub-
sequent studies showed that TSSP was predominantly ex-
pressed  in  the  endosomal  compartment  of  cortical TECs 
(cTECs; Bowlus et al., 1999; Carrier et al., 1999). This latter 
observation led to the hypothesis that TSSP may contribute 
to  the  generation  of  the  peptide  repertoire  presented  by 
MHC class II molecules in the thymus and consequently 
shape the CD4 T cell repertoire. TSSP-deficient (Tssp/) B6 
and nonobese diabetic (NOD) mice show normal thymic   
development of CD4 T cells expressing polyclonal TCR 
(Cheunsuk et al., 2005; Gommeaux et al., 2009; unpublished 
data). However, TSSP is necessary for the development of 
CD4 T cells expressing the class II–restricted OTII and Mari-
lyn transgenic TCRs (Gommeaux et al., 2009). These differ-
ent observations suggested that TSSP has likely no generic 
role in MHC class II presentation but may contribute to the 
diversification of the peptide repertoire presented by MHC 
class II molecules in the thymus. In this study, we evaluated 
the impact of this putative peptide-editing function of TSSP 
on the development of the functional polyclonal CD4 T cell 
repertoire of Tssp/ NOD mice.
RESULTS AND DISCUSSION
Tssp/ mice are immunocompetent
Because TSSP is thought to have a role in type 1 diabetes, 
we focused our study on Tssp/ NOD mice. To assess the 
role of TSSP in the development of a functional CD4 T cell 
repertoire, we immunized Tssp/ and WT control NOD 
mice with different protein Ags in CFA and analyzed the   
in vitro proliferative response of purified CD4 T cells upon 
restimulation  with  the  immunizing  Ag  and WT  APC.   
We found that the CD4 T cell responses of Tssp/ and   
WT  control  mice  to  KLH,  equine  Myo,  chicken  OVA, 
chicken conalbumin, and bovine RNase (RNase) were similar   
(Fig. 1). In sharp contrast, the CD4 T cell response of Tssp/ 
mice to HEL was dramatically reduced as compared with 
that of WT control mice (Fig. 1). Collectively, these results 
show that Tssp/ mice are immunocompetent and respond 
to most of the protein Ags tested to levels comparable with 
those of WT mice. However, Tssp/ mice are hyporespon-
sive to HEL.
The reduced response of Tssp/ mice to HEL does not result 
from defective processing of the HEL protein
Because TSSP is a putative protease of the MHC class II path-
way, it was possible that the defective response of Tssp/ 
mice to HEL may result from inefficient processing of the pro-
tein by APCs in vivo and consequently inefficient priming of 
the HEL-specific CD4 T cells. To address this issue, we first 
analyzed the presentation of HEL protein, and as control the 
Figure 1.  Reduced CD4 T cell proliferative response to HEL in 
Tssp/ mice. Tssp/ (KO) and WT control mice were immunized with 
the indicated protein. 10–11 d later, CD4 T cells were isolated from the 
draining LN and restimulated in vitro with WT spleen APCs and graded 
concentrations of the immunizing protein. For each Ag, one representa-
tive experiment out of at least two performed with one or two mice of 
each genotype is shown. Each symbol corresponds to one individual 
mouse. CAB, conalbumin.JEM VOL. 208, January 17, 2011  
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Figure 2.  The reduced response of Tssp/ mice to HEL is a CD4 T cell property. (A) IL-2 production by the HEL-specific T cell transfectant 
BW-HEL upon stimulation with splenic APCs from Tssp/ (KO) or WT control mice loaded with graded concentrations of HEL12–27 peptide or HEL pro-
tein, as indicated. One representative experiment out of four performed is shown. (B) WT or Tssp/ (KO) mice were primed with HEL protein (left) or 
HEL12–27 peptide (right). 11 d later, CD4 T cells were isolated from the draining LN and restimulated in vitro with WT spleen APCs and graded concen-
trations of HEL12–27 peptide. (C) WT and Tssp/ mice were primed in vivo, and their CD4 T cells were restimulated in vitro with WT spleen APCs and 
either HEL protein or HEL12–27 peptide, as indicated. Results are expressed as the ratio of the proliferation of TSSP-deficient T cells divided by that of 
WT control. The figure compiles the results of three to five independent experiments. Each symbol corresponds to one mouse. Horizontal bars repre-
sent the mean. One-sample t test showed that the responses of WT and Tssp/ mice are significantly different for all stimulation conditions (P < 
0.002). (D) WT and Tssp/ (KO) mice were primed in vivo with either WT or TSSP-deficient DCs pulsed with 40 ng HEL12–27 peptide, and their CD4 T 
cells were restimulated in vitro with WT spleen APCs and a titrated amount of HEL12–27 peptide. One representative experiment is presented in the left 
panel. The right panel combines results of three independent experiments expressed as the ratio of the proliferation of WT or TSSP-deficient T cells (X) 
divided by the mean value of the WT controls in the same experiment. Each symbol corresponds to one mouse. Horizontal bars represent the mean. 
Significant p-values are shown. (E) Purified LN CD4 T cells from HEL- or OVA-immunized WT and Tssp/ mice were labeled with CFSE and stimulated 
with WT splenocytes together with HEL12–27 peptide, OVA protein, or anti-CD3/CD28 antibodies, as indicated. Cell division was evaluated by analyzing 
CFSE dilution on gated CD4 T cells at day 3 and 6 of activation. The percentage of divided WT or TSSP-deficient (KO) CD4 T cells is shown. One repre-
sentative experiment out of four performed is shown. TSSP diversifies endogenous TCR repertoire | Viret et al.
Collectively, these results indicate that hyporesponsiveness 
of Tssp/ mice to HEL reflects a CD4 T cell property that is 
acquired during thymic differentiation. The observation that 
in addition to TEC thymic DCs lacking TSSP can also induce 
hyporesponsiveness to HEL reveals a new function of TSSP   
in the thymus. Indeed, in this latter case, TSSP-deficient DCs 
likely induce the deletion of some high affinity HEL-reactive 
CD4 T cells through the presentation of high affinity TCR 
ligands. Thus, the protease TSSP would prevent the genera-
tion of this HEL mimotope. Although we do not detect TSSP 
messenger RNA in Tssp/ thymi, we cannot formally ex-
clude  the  trivial  possibility  that  the  recombination  events 
during gene targeting of the Tssp locus led to a truncated 
polypeptide containing an HEL12–27 mimotope. Nonetheless, 
our observations further questioned the mechanism by which 
TSSP-deficient TECs, and more likely cTECs, may alter the 
HEL-specific CD4 T cell repertoire. Indeed, cTECs can in-
duce positive selection but also negative selection of some 
self-reactive T cells (Goldman et al., 2005; McCaughtry et al., 
2008; Klein et al., 2009). Therefore, it is possible that cTECs 
lacking TSSP may induce negative selection of some HEL-
specific  CD4 T  cells  either  directly  or  indirectly  through 
cross-presentation of self-determinants by thymic DCs.
Distinct TCR repertoire features of HEL-responsive  
CD4 T cells from Tssp/ mice
The aforementioned results suggested that TSSP deficiency 
might lead to modification of the TCR repertoire of HEL-
responsive CD4 T cells. To address this question, we first ex-
amined  whether TSSP  deficiency  may  alter  the V  chain 
usage of HEL12–27-specific CD4 T cells. For this experiment, 
we  isolated  CD4 T  cells  from  HEL-primed  mice,  labeled 
them  with  CFSE,  and  stimulated  them  in  vitro  with  the 
HEL12–27 peptide and syngeneic APC. 5–6 d later, the HEL-
responsive CD4 T cells were FACS sorted based on CFSE di-
lution, and expression of the different V gene segments was 
analyzed by real-time PCR. Parallel experiments showed that 
the V usage of naive CD4 T cells from unprimed WT and 
Tssp/ mice were similar (Fig. 4). We found in the HEL-
specific CD4 T cells from WT mice a marked amplification of 
the V6 segment, representing 29.9 ± 13.2% (mean ± SD;   
n = 4) of the total  V gene usage and a fourfold increase com-
pared with naive CD4 T cells (Fig. 4). Among other V  
segments, only V7 values were significantly increased in 
HEL12–27-responsive CD4 T cells from all WT mice relative to 
CD4 T cells from naive mice (fourfold increase). However, 
V7 usage by HEL-specific CD4 T cells was not significantly 
different from that of other V segments. Therefore, in NOD 
mice, HEL12–27-specific CD4 T cells preferentially use V6 
segments. Importantly, such V6 bias was not observed when 
the same CD4 T cells were stimulated with anti-CD3/CD28 
mAbs (Table S1).
This prominent V6 segment usage was not observed for 
HEL12–27-responsive CD4 T cells from HEL-primed Tssp/ 
mice. Indeed, for this CD4 T cell population, the representation 
of V6 segments (17.8 ± 7.9%; n = 5) was not significantly 
Impaired thymic selection of HEL-specific CD4 T cells  
in Tssp/ mice
The aforementioned results suggested that TSSP might be 
necessary for the intrathymic development of high affinity 
HEL-specific CD4 T cells. In agreement, we found that the 
thymic development of CD4 T cells expressing a given HEL-
specific IAg7-restricted TCR was impaired in Tssp/ mice as 
compared with WT NOD mice (Fig. S1). We next examined 
whether TSSP deficiency may likewise impact on the genera-
tion of a polyclonal HEL-specific CD4 T cell repertoire using 
BM chimeras. TSSP is highly expressed by cTEC (Bowlus   
et al., 1999; Carrier et al., 1999; Cheunsuk et al., 2002) but 
also, at lower levels, by thymic DCs (unpublished data). There-
fore, we examined the effect of TSSP deficiency in radio- 
resistant TECs on the differentiation of some HEL-specific 
CD4 T cells by injecting WT BM cells into lethally irradiated 
Tssp/ NOD-C° mice (WT → KO) or, as control, into 
NOD-C° host (WT → WT). Conversely, to assess the role 
of TSSP-deficient BM-derived thymic APCs in deleting   
some HEL-specific CD4 T cells, we reconstituted irradiated   
NOD-C° mice with a mix of WT and NOD-C° TSSP-
deficient BM cells (WT + C°-KO → WT). We found that 
both WT  →  KO  and WT  +  C°-KO  → WT  chimeras 
showed a reduced CD4 T cell response to HEL that was com-
parable with that observed in Tssp/ mice or control chi-
mera, in which both the TECs and thymic APCs lack TSSP 
expression (Fig. 3).
Figure .  Impaired thymic selection of HEL-specific CD4 T cells in 
Tssp/ mice. WT or Tssp/ (KO) mice were lethally irradiated before 
reconstitution with WT BM cells (WT) or a 1:1 mix of WT and NOD-C° 
TSSP-deficient (C°-KO) BM cells, as indicated (BM → host). 8–10 wk 
after reconstitution, chimeras were immunized with HEL protein, and 7 d 
later, their CD4 T cell proliferative response to 10 µg/ml HEL12–27 pulsed 
WT APCs was analyzed. The results of three independent experiments are 
expressed as the ratio of the proliferation of WT or TSSP-deficient CD4  
T cells (X) divided by the mean value of the WT control chimeras in the 
same experiment. Each symbol corresponds to one individual chimera. 
Horizontal bars represent the mean. Significant p-values are shown.JEM VOL. 208, January 17, 2011  
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of them (sequence 32, IFDRGSAETL) was clearly more fre-
quently used by CD4 T cells from Tssp/ mice: found 22 
times among three out of five Tssp/ mice versus 3 times 
for one out of four WT mice (Table I). This CDR3 was thus 
overtly more available within the CD4 T cell repertoire of 
Tssp/ mice and presumably did not allow for a robust CD4 
T cell response to HEL challenge. Finally, although no domi-
nant CDR3 rearrangements were revealed by this analysis in 
WT mice, two additional dominant CDR3 rearrangements 
were found in Tssp/ mice (sequence 38, SILGGNYAEQ; 
sequence 45,  SWDFLNTGQL).
To further compare the HEL-specific TCR repertoire of 
WT and Tssp/ mice, we amplified and sequenced V6-J2.1 
joints, a rearrangement which was frequently used by HEL12–27-
responsive CD4 T cells in both strains of mice. The analysis of 
92 clones revealed that V6-J2.1 joints found only in WT 
CD4 T cells were characterized by a high frequency of posi-
tively charged residues and prevalence of an arginine residue, 
relative to their counterparts from Tssp/ mice (Table II). 
This  CDR3  feature  correlated  with  a  marked  increase  in 
D1.1 gene segment usage (10/12 CDR3 sequences), sug-
gesting  that  these  rearrangements  may  confer  a  better  fit.   
This analysis also revealed the dominant repertoire of HEL-
specific CD4 T cells in WT mice (SRTDYAEQ, SISNYAEQ,   
and SILGGNYAEQ). Only one of these rearrangements 
(SILGGNYAEQ) was also dominant and public in Tssp/ 
mice (Table II). To confirm these observations, we estimated, 
by real-time RT-PCR, the distribution of these three clono-
types among HEL-specific CD4 T cells in WT and Tssp/ 
mice. We first amplified the V6-C segments and used 
clonotype-specific primers for the real-time PCR amplification. 
Although the SILGGNYAEQ and SRTDYAEQ sequences 
were public and dominant in WT control mice, only the for-
mer was also public and dominant in Tssp/ mice (Fig. S2 B).   
higher than that of V1, V2, V7, V8.2, and V8.3 segments 
(Fig. 4). However, in this case too,  V6 and  V7 gene usage by 
HEL-specific CD4 T cells was significantly increased as com-
pared with that of naive CD4 T cells (2.4- and 3.7-fold, 
respectively). Thus, the reduced CD4 T cell response of 
Tssp/ mice to HEL12–27 correlated with a lowered usage of 
the V6 gene segment.
To further examine the impact of TSSP deficiency on the 
HEL-specific TCR repertoire, we cloned and sequenced their 
V6-J-C region. The analysis of 132 clones derived from 
the aforementioned four WT and five Tssp/ mice identi-
fied 54 distinct CDR3 sequences that could be ordered into 
three groups (Table I). A first group included sequences found 
only in WT CD4 T cells (42% of sequences; sequences 1–23), 
and a second group included those found only in CD4 T cells 
from Tssp/ mice (37% of the sequences; sequences 35–54). 
Finally, 20% of sequences could be amplified from both types 
of cells (sequences 24–34).
There were no significant differences in the J segment 
usage  between V6  chains  found  in  HEL12–27-responsive 
CD4 T cells from WT or Tssp/ mice. Analysis of all the  V6 
CDR3 sequences points to several interesting findings. First, 
although HEL-responsive CD4 T cells from Tssp/ mice 
had accomplished fewer divisions, they showed less CDR3 
diversity. Indeed, repeated occurrences of few V6 rearrange-
ments were found for TSSP-deficient but not for WT CD4 
T cells. Thus, the percentage of unique sequences among the 
total number of CDR3 sequences for WT mice was 73, 100, 
85, and 73% (mice 1–4, respectively), and for Tssp2/2 mice it 
was 33, 37%, 73, 83, and 42% (mice 1–5, respectively; Table I). 
Because these clones showed the same nucleotide sequence 
(unpublished data), they likely derive from the same naive 
CD4 T cell precursor that had a selective advantage. Second, 
among CDR3 sequences shared by both types of cells, one 
Figure 4.  V gene segment usage by naive and HEL12–2-responsive CD4 T cells from Tssp/ and WT control mice. CD4 T cells isolated from 
HEL-primed WT or Tssp/ mice were CFSE labeled and stimulated with HEL12–27 peptide in the presence of irradiated WT splenocytes. After 5–6 d of cul-
ture, dividing CD4 T cells were FACS sorted before RT-coupled real-time PCR analysis. Alternatively, LN CD4 T cells were isolated from 9–13-wk-old naive 
mice. Box and whiskers graph shows the V gene usage for naive or HEL-specific CD4 T cells isolated from WT or Tssp/ (KO) mice (n = number of mice). 
Horizontal bars show the median values, boxes show the 25th and 75th percentile, and bars show the minimal and maximal values. In WT mice, V6  
usage was significantly higher than that of all other V genes, except V7 (P < 0.05). The p-value of those V with an increased representation in  
CD4 T cells from primed mice as compared with that of naive mice is shown (*, P < 0.05; **, P < 0.01). TSSP diversifies endogenous TCR repertoire | Viret et al.
Table I.  V6-C joint of HEL12–27-specific CD4 T cells
Sequence no. Sequences (aa) J L nCh WT Tssp/
  1 2 3 4 1 2 3 4 5
1 SIWQGRV 1.1 7 1 1
2 SIGGNTEV 1.1 8 1 1
3 WDRGGATEV 1.1 9 1 1
4 SDRVHSDY 1.2 8 0 1
5 SIDTSGNTL 1.3 9 1 1 1
6 SIRTGGFEQ 2.1 9 0 1
7 SRTDYAEQ 2.1 8 1 1
8 SIWGGNYAEQ 2.1 10 1 1
9 SSRDRNYAEQ 2.1 10 0 1
10 SIRDRNYAEQ 2.1 10 0 1
11 SVRDKNTGQL 2.2 10 1 1
12 SIWGSAETL 2.3 9 1 1 1
13 SRLAHRAETL 2.3 10 2 1
14 SLGTAETL 2.3 8 1 1
15 TPAGSSAETL 2.3 10 1 1
16 SIVGGRNTL 2.4 9 1 1
17 SGTQDTQ 2.5 7 1 1
18 SIDWGNQDTQ 2.5 10 2 1
19 SIGGTGGYEQ 2.7 10 1 1
20 SIAWTGGYEQ 2.7 10 1 1
21 SIEDRYEQ 2.7 8 2 1
22 SIADRYEQ 2.7 8 1 2
23 SINRGEQ 2.7 7 0 1
24 SINERL 1.4 6 0 1 2
25 SIGRGERL 1.4 8 1 1 1
26 SIGTISNERL 1.4 10 0 1 1
27 SISNYAEQ 2.1 8 1 1 2 2 1
28 RGQGNNYAEQ 2.1 10 0 1 1
29 TPDRNTGQL 2.2 9 0 1 2 1 2
30 SIISAETL 2.3 8 1 1 1 2
31 SLESAETL 2.3 8 2 1 1 2 1 2
32 IFDRGSAETL 2.3 10 1 3 8 7 7
33 SILWGPYEQ 2.7 9 1 1 3
34 SSGLSYEQ 2.7 8 1 2 1
35 SIYRGHGNTL 1.3 10 2 1
36 SIGFSNERL 1.4 9 0 1
37 TLTPGAEQ 2.1 8 1 1
38 SILGGNYAEQ 2.1 10 1 4 4 2
39 SIVWGGIDAEQ 2.1 11 2 1
40 SPDWGRNYAEQ 2.1 11 1 1
41 RQDTQ 2.2 4 0 1
42 SLLQNTGQL 2.2 9 0 1
43 SLDRNTGQL 2.2 9 0 1
44 SMGDITGQL 2.2 9 1 2
45 SWDFLNTGQL 2.2 10 1 2 4 2
46 SIRTGNTGQL 2.2 10 1 1
47 TGAGSSAETL 2.3 10 1 1
48 WQTDQ 2.5 5 1 1JEM VOL. 208, January 17, 2011  
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with alteration of the TCR repertoire of the HEL-specific 
CD4 T cells. Thus, TSSP is necessary for the intrathymic de-
velopment of CD4 T cells that confer robust anti-HEL re-
sponse but dispensable for the development of CD4 T cells 
specific  for  KLH,  Myo,  OVA,  conalbumin,  and  RNase.   
Although this analysis is still limited, these results suggest that 
the development of the functional CD4 T cell repertoire   
corresponding to roughly 15% of the Ags tested requires TSSP 
function in the thymus. Thus, TSSP contributes substantially 
to the diversification of the functional CD4 T cell repertoire.
Furthermore, the representation of the SRTDYAEQ clonotype 
was very low in Tssp/ mice, representing <10% of that de-
tected in WT mice (Fig. S2 A). Regarding the SISNYAEQ rear-
rangement,  the  combined  sequence  analysis  (Table  II)  and 
real-time PCR analysis (Fig. S2) indicated that this rearrange-
ment is public but not dominant in both strains of mice. Overall, 
these results show that one of the public rearrangements found 
in WT mice (SRTDYAEQ) was barely used by Tssp/ mice.
Altogether, the aforementioned data indicate that hypore-
sponsiveness of Tssp/ mice to HEL challenge is associated 
Table I.  V6-C joint of HEL12–27-specific CD4 T cells (Continued)
Sequence no. Sequences (aa) J L nCh WT Tssp/
  1 2 3 4 1 2 3 4 5
49 SRLGGDTQ 2.5 8 0 1
50 SIGIEQ 2.7 6 1 2
51 SIVGAGEQ 2.7 8 1 1
52 SRGLGDYEQ 2.7 9 1 1
53 SIRRGHYEQ 2.7 9 2 4 1
54 SMGWGGLSYEQ 2.7 11 1 1
Compilation of 54 distinct CDR3 sequences of V6 TCR chain from purified HEL-responsive CD4 T cells from four WT (1–4) and five Tssp/ (1–5) HEL-immunized mice. For 
each sequence, the relevant J segment, CDR3 length (L), and CDR3 net charge (nCh) are indicated. Negatively and positively charged amino acids are shown underlined and 
in bold, respectively. The number of times each sequence occurred in individual mice is shown and appears when corresponding to dominant CDR3 sequences. The 54 
individual sequences correspond to a total of 132 clones analyzed. .
Table II.  V6-J2.1 joint of HEL12–27-specific CD4 T cells
Sequences (aa) L nCh WT Tssp/
1 2 3 4 1 2 3 4 5
SRTDYAEQ 8 1 2 4 1
SIRTGGFEQ 9 0 1
SRQGGDTQY 9 0 1
SIWGGNYAEQ 10 1 1
SSRDRNYAEQ 10 0 1
SIRDRNYAEQ 10 0 1
FPRIPGKNYAEQ 12 1 1
SISNYAEQ 8 1 1 1 8 8 1 1 1 1
SIWDRYAEQ 9 1 2 2 1
STGGNYAEQ 9 1 2 3
SILGGNYAEQ 10 1 2 4 3 6 4 5 2 2
RGQGNNYAEQ 10 0 2 1 1 1
TLTPGAEQ 8 1 1
RQQNYAEQ 8 0 1
SIWDGYAEQ 9 2 1
PIQENYAEQ 9 2 2
SILWGPYEQY 10 1 1
RGQGNRCAEQ 10 1 1
SIVWGGIDAEQ 11 2 1
SPDWGRNYAEQ 11 1 2 4
Compilation of 18 distinct CDR3 sequences derived from 92 clones of V6-J2.1 joints from purified HEL-responsive CD4 T cells from four WT (1–4) and five Tssp/ (1–5) 
HEL-immunized mice. For each sequence, the CDR3 length (L) and CDR3 net charge (nCh) are indicated. Negatively and positively charged amino acids are shown underlined 
and in bold, respectively. The number of times each sequence occurred in individual mice is shown.10 TSSP diversifies endogenous TCR repertoire | Viret et al.
using SuperScript II enzyme (Invitrogen) according to manufacturers’ instruc-
tions.  V expression pattern was assessed by real-time PCR using  V-specific 
primers and probes as described previously that allowed for the detection of 
24 different V (Lim et al., 2002; Pannetier et al., 1993). The probe sequence 
is 5-AAATGTGACTCCACCCAAGGTCTCCTTGTT-3.
The relative usage of each V expressed as a percentage was calculated 
using the following equation:
	
UsageVβx
Ct x Ct y
y
y =
× ( ) −
=
=
∑
100
2 2
1
24
( )
, 	
in  which  Ct(x)  is  the  fluorescence  threshold  cycle  number  measured   
for Vx.
For sequencing, the PCR reaction was made using Phusion High-Fidelity 
DNA polymerase (Finnzymes) and V6 forward primers together with C 
or J2.1 reversed primers. The PCR product was directly subcloned using 
TOPO TA cloning kit for sequencing (Invitrogen).
Statistics. Unpaired t tests were calculated using Prism software (GraphPad 
Software, Inc.). Unpaired values are shown. For Fig. 2 C, one-sample t tests 
were run using Prism software.
Online supplemental material. Fig. S1 shows the intrathymic develop-
ment of CD4 T cells expressing a given HEL-specific IAg7-restricted TCR 
in WT and Tssp/ thymic environment. Fig. S2 shows the distribution, 
among HEL-specific CD4 T cells from WT and Tssp/ mice, of the three   
dominant  clonotypes  shown  in Table  II  (SRTDYAEQ,  SISNYAEQ,  and   
SILGGNYAEQ).  Table S1 shows the  V gene usage of anti-CD3/CD28–stim-
ulated CD4 T cells from WT and Tssp/ mice. Online supplemental material 
is available at http://www.jem.org/cgi/content/full/jem.20100027/DC1.
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